Tobacco quitline performance : Comparing the impacts of early cessation and proactive re-engagement on callers' smoking status at follow-up at 12 months

© 2023 Cassidy D.G. et al..

INTRODUCTION: While tobacco Quitlines are effective in the promotion of smoking cessation, the majority of callers who wish to quit still fail to do so. The aim of this study was to determine if 12-month tobacco Quitline smoking cessation rates could be improved with re-engagement of callers whose first Quitline treatment failed to establish abstinence.

METHODS: In an adaptive trial, 614 adult smokers, who were active duty, retired, and family of military personnel with TRICARE insurance who called a tobacco Quitline, received a previously evaluated and efficacious four-session tobacco cessation intervention with nicotine replacement therapy (NRT). At the scheduled follow-up at 3 months, callers who had not yet achieved abstinence were offered the opportunity to re-engage. This resulted in three caller groups: 1) those who were abstinent, 2) those who were still smoking but willing to re-engage with an additional Quitline treatment; and 3) individuals who were still smoking but declined re-engagement. A propensity score-adjusted logistic regression model was generated to compare past-7-day point prevalence abstinence at 12 months post Quitline consultation.

RESULTS: Using a propensity score adjusted logistic regression model, comparison of the three groups resulted in higher odds of past-7-day point prevalence abstinence at follow-up at 12 months for those who were abstinent at 3 months compared to those who re-engaged (OR=9.6; 95% CI: 5.2-17.8; Bonferroni adjusted p<0.0001), and relative to those who declined re-engagement (OR=13.4; 95% CI: 6.8-26.3; Bonferroni adjusted p<0.0001). There was no statistically significant difference in smoking abstinence between smokers at 3 months who re-engaged and those who declined re-engagement (OR=1.39; 95% CI: 0.68-2.85).

CONCLUSIONS: Tobacco Quitlines seeking to select a single initiative by which to maximize abstinence at follow-up at 12 months may benefit from diverting additional resources from the re-engagement of callers whose initial quit attempt failed, toward changes which increase callers' probability of success within the first 3 months of treatment.

TRIAL REGISTRATION: This study is registered at clinicaltrials.gov (NCT02201810).

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Tobacco induced diseases - 21(2023) vom: 05., Seite 24

Sprache:

Englisch

Beteiligte Personen:

Cassidy, Daniel G [VerfasserIn]
Wang, Xin-Qun [VerfasserIn]
Mallawaarachchi, Indika [VerfasserIn]
Wiseman, Kara P [VerfasserIn]
Ebbert, Jon O [VerfasserIn]
Blue Star, John A [VerfasserIn]
Aycock, Chase A [VerfasserIn]
Estevez Burns, Rosemary [VerfasserIn]
Jones, John R [VerfasserIn]
Krunnfusz, Andrea E [VerfasserIn]
Halbert, Jennifer P [VerfasserIn]
Roy, Natalie M [VerfasserIn]
Ellis, Jordan M [VerfasserIn]
Williams, Juinell B [VerfasserIn]
Klesges, Robert C [VerfasserIn]
Talcott, Gerald W [VerfasserIn]

Links:

Volltext

Themen:

Abstinence
Journal Article
Nicotine replacement therapy
Proactive re-engagement
Quitline
Tobacco cessation intervention

Anmerkungen:

Date Revised 18.02.2023

published: Electronic-eCollection

ClinicalTrials.gov: NCT02201810

Citation Status PubMed-not-MEDLINE

doi:

10.18332/tid/159125

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM353051551